|
FBRX | Forte Biosciences, Inc. |
|
|
FBRX | Forte Biosciences, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.02 |
| Leverage | 47.81% |
| Market Cap | $ 436.0m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -34.1m |
| Margin | -10441.39% |
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California.